Author | Frank Diamond

Articles

FDA Approves Additional Dose of COVID-19 Vaccine for Immunocompromised Patients

The US Food and Drug Administration (FDA) announced it has authorized a third dose of either the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccines for patients with compromised immune systems, such as patients with rheumatic disease.